Posted by Michael Wonder on 18 May 2021
Pharmaceutical company AbbVie inflated prices for two major drugs, House Oversight report says
18 May 2021 - The House Oversight and Reform Committee found that the company increased prices for Humira and Imbruvica.
Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. who take the drugs Humira and Imbruvica, a report released Tuesday by the House Oversight and Reform Committee found.
The committee concluded that the price increases led to billions of dollars in corporate revenue and hefty bonuses for company executives.
